{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:23Z","timestamp":1786119683764,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/jcp.0b013e318210b4ee","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T14:30:37Z","timestamp":1299076237000},"page":"259-261","source":"Crossref","is-referenced-by-count":11,"title":["Randomized, Open Naturalistic, Acute Treatment of Panic Disorder With Clonazepam or Paroxetine"],"prefix":"10.1097","volume":"31","author":[{"given":"Antonio E.","family":"Nardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre M.","family":"Valen\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael C.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Amrein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Sardinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle N.","family":"Levitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valfrido L.","family":"de-Melo-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana C.","family":"de O. e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 B.","family":"Veras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele P.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gast\u00e3o L.","family":"Soares-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael T.","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Mezzasalma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcele R.","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"de Cerqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime E.","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"Versiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-33-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2005.05.003","article-title":"A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia.","volume":"88","author":"Mitte","year":"2005","journal-title":"J Affect Disord"},{"key":"R2-33-20210128","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004714-199710000-00008","article-title":"Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group.","volume":"17","author":"Rosenbaum","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"R3-33-20210128","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4088\/JCP.v66n0105","article-title":"Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.","volume":"66","author":"Sheehan","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R4-33-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/JCP.0b013e3181dcb2f3","article-title":"Tapering clonazepam in patients with panic disorder after at least 3 years of treatment.","volume":"30","author":"Nardi","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"R5-33-20210128","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4088\/JCP.v60n0907","article-title":"Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.","volume":"60","author":"Moroz","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R6-33-20210128","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1590\/S0004-282X2000000600008","article-title":"Double-blind clonazepam vs placebo in panic disorder treatment.","volume":"58","author":"Valenca","year":"2000","journal-title":"Arq Neuropsiquiatr"},{"key":"R7-33-20210128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psychres.2005.05.011","article-title":"A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam.","volume":"137","author":"Nardi","year":"2005","journal-title":"Psychiatr Res"},{"key":"R8-33-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1586\/14737175.4.2.191","article-title":"Paroxetine in panic disorder: clinical management and long-term follow-up.","volume":"4","author":"Dannon","year":"2004","journal-title":"Expert Rev Neurother"},{"issue":"suppl 5","key":"R10-33-20210128","first-page":"7","article-title":"Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.","volume":"65","author":"Chouinard","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"suppl 5","key":"R11-33-20210128","first-page":"1","article-title":"Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder.","volume":"155","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R12-33-20210128","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/02698811030173009","article-title":"Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder.","volume":"17","author":"Pollack","year":"2003","journal-title":"J Psychopharmacol"},{"key":"R13-33-20210128","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1517\/14740330802423168","article-title":"Paroxetine: safety and tolerability issues.","volume":"7","author":"Marks","year":"2008","journal-title":"Expert Opin Drug Saf"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e318210b4ee","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:55:35Z","timestamp":1786042535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201104000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318210b4ee","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}